Daily Stock List
HighLight Networks, Inc. (HNET)
We are highlighting HighLight Networks, Inc. (HNET), here at the QualityStocks Daily Newsletter.
Incorporated on June 21, 2007, HighLight Networks, Inc. is a development stage, wireless broadband networking company. The Company is in the business of planning, development and operation of private and public access wireless broadband networks using Wi-Fi (IEEE 802.11) and WiMAX (IEEE 802.16) wireless technologies to provide business and residential customers "last mile" connectivity for rapid as well as reliable Internet communications.
HighLight Networks lists on the OTC Markets' OTCQB. The Company has their corporate headquarters in Liverpool, New York. Mr. Alfonso C. Knoll is the Company's Chief Executive Officer, President, and Director. Mr. Joseph C. Passalaqua is their Chief Financial Officer, Treasurer, Secretary, and Director.
HighLight Networks' operations currently consist of product and technology review, analysis and system design and negotiations for system placement and third party contract services. As of December 31, 2012, the Company had no agreements with sub-distributors relating to distribution commitments or guarantees that had not been recognized in the statement of operations.
In addition to basic Wireless Broadband Internet connectivity, the Company offers additional services to enhance their offerings. These may include low cost reliable customer packaged services including Voice over Internet Protocol (VoIP) usage and unlimited plans.
Furthermore, HighLight Networks has recently expanded their business to include the repurposing, resale, and recycling of networking and telecom hardware. The Company actively purchases working and non-working electronic equipment on a nationwide basis.
This past January, HighLight Networks announced their used cell phone and tablet purchasing program. Clients can send individual phones or tablets to the Company and receive a check or online payment after the items are received. HighLight pays for working and non-working items. There is no limit to the amount a client can mail in.
The program allows individuals and corporate partners to sign up with HighLight and earn commissions for cell phones and products referrals. HighLight Networks accepts everything from single cell phones to entire truckloads of overstock, returns, and end of life products.
HighLight Networks, Inc. (HNET), closed Thursday's trading session at $1.25, up 4.17%, on 4,000 volume with 3 trades. The average volume for the last 60 days is 867 and the stock's 52-week low/high is $0.50/$4.25.
SurePure, Inc. (SURP)
Today we choose to report on SurePure, Inc. (SURP), here at the QualityStocks Daily Newsletter.
Trading on the OTCQB, SurePure, Inc. is a worldwide leader in liquid photopurification. This is the green alternative to pasteurization and chemicals. Using their patented 'Turbulator' technology, SurePure systems use UV-C light to purify microbiologically sensitive liquids. The design of the Company's technology is to deliver food-grade solutions. SurePure is based in New York, New York.
In addition, the Company's technology can be harnessed to improve processing liquids such as water, brines and sugar syrup solutions, and animal blood plasma. Their technology offers greater microbiological efficacy than conventional UV systems. It is effective for clear and turbid liquids. SurePure also provides opportunities for the development of innovative and differentiated products with desired consumer benefits, guaranteed food safety, as well as sound commercial benefits.
The Company's liquid photo-purification technology purifies the aforementioned turbid liquids. These include milk, beer, fruit juice, wine, carbonated beverages and an array of industrial applications. SurePure's patented technology utilizes a specific band of ultraviolet light to provide a green alternative to heat and chemicals in the purification of turbid liquids.
In January, SurePure announced that GEA Farm Technologies of Naperville, Illinois renewed their worldwide license for SurePure's ultraviolet (UV) calf milk purifier technology through 2018. GEA Farm Technologies is part of the GEA Group. GEA Farm Technologies markets SurePure's technology for feeding dairy calves under the brand name UV Pure by way of their subsidiaries in more than 60 nations.
Last month, SurePure announced that Sigma Alimentos would purchase a minimum of three of their SurePure ultraviolet (UVC) photopurification systems. Sigma Alimentos has been testing SurePure equipment for more than 12 months. The order represents a significant step forward for SurePure in the validation of their technology. Sigma Alimentos is a major Mexican food producer. Sigma is the Mexican leader in the production and distribution of refrigerated and frozen foods. Sigma is established as the company with the largest number of products on the tables of Mexican families.
SurePure, Inc. (SURP), closed today at $1.25, up 19.05%, on 68,300 volume with 13 trades. The stock's 52-week low/high is $0.84/$1.52.
United Resource Holdings Group, Inc. (URHG)
Today we are reporting on United Resource Holdings Group, Inc. (URHG), here at the QualityStocks Daily Newsletter.
United Resource Holdings Group, Inc. focuses on gold, silver and copper mining and other natural resources. The Company established in 1951 as Silver Mountain Lead Mines, Inc. They were renamed United Resource Holdings Group, Inc. in February of 2007. The Company operates via their two subsidiaries, Dun Glen Mining Corp. and United Milling & Refining Corp. United Resource Holdings Group has their headquarters in Reno, Nevada.
The Company focuses on the acquisition of mining equipment, mineral-bearing materials, and the development of gold and other precious commodity projects that demonstrate a reasonable probability for near-term production and revenue. United Resource also holds a controlling interest in a beneficiation process plant that recovers precious metals from mineral ores and ore concentrates on behalf of their captive mining properties and on behalf of third-party mining companies.
Their Dun Glen subsidiary is an exploration and mining company. They focus on the acquisition and development of gold and other precious metal commodity projects. Dun Glen Mining has the rights to numerous patented and unpatented mining claims located in Township 33N, Range 36E, Sections 15 and 16, Pershing County, Nevada. This area is referred to as the Dun Glen Mine. It is Dun Glen Mining's sole placer mining property at this time.
Their United Milling & Refining subsidiary is a downstream precious metals and mineral ore processing company. They focus on the beneficiation and smelting of gold and other precious metals. United Milling & Refining operates a 32,000 square foot facility; they provide their services to small and mid-sized, independent mining operations throughout North America.
Last week, United Resource Holdings Group announced that United Minerals Investment Corp., a wholly owned subsidiary of the Company, executed a letter agreement for the financing, acquisition and processing of mineral-bearing materials. United Minerals entered into a letter agreement with Northern Gold Producers, LLC, a company headquartered in Las Vegas, Nevada, regarding the financing, acquisition and processing of certain mineral-bearing materials that may undergo identification by United Minerals or their Nevada-based processing partner.
United Resource Holdings Group, Inc. (URHG), closed Thursday at $0.288, down 3.29%, on 44,600 volume with 12 trades. The stock's 52-week low/high is $0.18/$0.99.
Kelso Technologies, Inc. (KEOSF)
Today we are reporting on Kelso Technologies, Inc. (KEOSF), here at the QualityStocks Daily Newsletter.
Founded in 1987, Kelso Technologies, Inc. is a railroad equipment supplier that lists on the OTCQX International. The Company produces and sells proprietary tank car components used in the safe loading, unloading and containment of hazardous materials during transport. An innovator in the railroad equipment supply industry in North America, Kelso engages in the design, engineering, sales, production and distribution of patented technologies. Kelso Technologies has their headquarters in North Delta, British Columbia.
The design of the Company's products is specifically to provide economic and operational advantages while reducing the potential effects of human error and environmental harm during the transport of hazardous materials. Kelso has available a series of external pressure relief valves, eduction tubes and a new manway design for rail tank cars and roadway tank trailers. The Company's external pressure relief valve replaces current product designs that are 50 years old.
The Kelso pressure relief valve is for low-pressure, class 111A tank cars. The Kelso external pressure relief valve design replaces the internal helical spring, internal valve stem and internal spring guide tube with up to 38 external constant force springs. These place an external valve stem in compression. It is the only high-flow "external" valve available in the market today.
The Kelso Klincher™ manway replaces the old eyebolt versions that are close to 100 years old. It is faster, easier and safer for workers to use. The Kelso Klincher™ price is almost the same as the outdated models. The Company also offers their Kelso Tiger Tube™. This is used to load and unload highly corrosive chemicals from rail tank cars or roadway tank trailers.
Recently, Kelso Technologies reported that the Company has become an associate member of the Association of American Railroads (AAR). The AAR is the rail industry's governing organization that sets standards for railroad transportation with the goal that America's freight railroads operate the safest; cost effective; and environmentally sound rail transport systems worldwide. AAR members include the major freight railroads in the U.S, Canada and Mexico.
Kelso Technologies, Inc. (KEOSF), closed Thursday's session at $0.855, down 5.00%, on 33,000 volume with 8 trades. The stock's 52-week low/high is $0.488/$0.914.
Kitrinor Metals, Inc. (KIT.V)
Today we are highlighting Kitrinor Metals, Inc. (KIT.V), here at the QualityStocks Daily Newsletter.
Kitrinor Metals, Inc. is currently focusing on three exploration projects located in northern Ontario. These properties are Culroc, Caley Lake, and Feather River-Bayview. The Company's shares trade on the TSX Venture Exchange. Kitrinor Metals has their corporate headquarters in Toronto, Ontario.
Their Culroc property consists of one claim (two units). It is strategically positioned on the Edleston Zone currently undergoing exploration by SGX Resources, Inc. The property is in the northwestern portion of Sothman Township, approximately 60 kilometers south of Timmins, Ontario.
Kitrinor Metals' Caley Lake property consists of eight unpatented claims (90 units) located in the Patricia Mining Division. This property is approximately 25 kilometers southwest of Pickle Lake where drilling is presently taking place by Tri Origin Exploration under an option with Kitrinor Metals. The Caley Lake property surrounds Barrick Gold's Koval property that has a drilled inferred inventory of 310,000 tonnes at 6.9 g/t gold.
The Feather River-Bayview property consists of seven staked claims (76 units, 1,216 hectares). This property is in St. Germain Township, approximately 42 kilometers west of Wawa, Ontario.
Yesterday, Kitrinor Metals announced the results of a preliminary drill program on their Culroc property of six holes totaling 2,229 meters that they completed during the period December 14, 2012 to January 22, 2013. The Culroc property is surrounded by claims controlled by SGX Resources.
On January 26, 2012, SGX Resources announced the discovery of a new gold zone on their adjacent acreage named the Edelston Zone. SGX has traced this zone by diamond drilling along strike and immediately to the north of the Culroc claims. The Edelston Zone dips to the south and Kitrinor Metals' preliminary drill program targeted the down dip extension of the Edelston Zone beneath the Culroc claims.
All of the holes intersected wide core lengths of deformed and altered metavolcanic and ultramafic rock containing scattered anomalous gold values. Interpretation of the collected data suggests that hole C-12-01 cut the interpreted down dip extension of the close by Edelston Zone.
Kitrinor Metals, Inc. (KIT.V), closed Thursday's trading session at $0.025, down 16.67%, on 27,000 volume. The stock's 52-week low/high is $0.02/$0.25.
Discovery Gold Corp. (DCGD)
Today we are reporting on Discovery Gold Corp. (DCGD), here at the QualityStocks Daily Newsletter.
Listed on the OTCQB, Discovery Gold Corp. is an emerging mineral exploration company. Through their 100 percent owned Ghanaian subsidiary company, Discovery Gold Ghana, Ltd., (DGG) Discovery Gold owns a 95 percent beneficial interest in an option to acquire the exclusive rights to explore the Edum Banso Gold Project within the historic and prolific Ashanti Gold Belt located in Ghana, West Africa.
The Edum Banso gold project covers an area of approximately 8 square miles (20.6 square kilometers). The project lies approximately 168 miles (270 kilometers) due west of Accra, the capital of Ghana. The project is near to major producing gold mines and recent discoveries of gold deposits.
Discovery Gold has been focusing on developing their proposed exploration program for the Edum Banso Gold Project. The Company has also been focusing on strengthening their balance sheet so they're in a position to finance the exploration work required. Discovery Gold received final governmental approval (effective December 31, 2012) for the contractual assignment of the option to explore the Edum Banso Gold Project in Ghana from Xtra-Gold Resources to Discovery Gold Ghana.
On January 9, 2013, the Company entered into an agreement with CME Enterprises, Ltd. to undertake historic data compilation, site reconnaissance, and rock sampling work on Edum Banso. CME completed their initial site reconnaissance, conducted meetings with relevant surface rights holders, and collected additional samples of rock outcrops and subcrops from high priority targets on the Edum Banso property during the month of January 2013.
Discovery Gold has completed planning of their pre-drilling exploration program for the Edum Banso Gold Project. The Company's intention is to focus the next round of exploration on two select high-priority anomalous gold targets. They chose these high-priority exploration targets because of the earlier encouraging results and closeness to the location and geological features thought to be associated with the source of gold presently being open pit mined by Golden Star Resources close to 1 km from the property border.
On Tuesday of this week, Discovery Gold announced that geologic consultants from CME received assay results from limited rock sampling. CME has substantially completed their preliminary "Assessment of the Edum Banso Property" for Discovery Gold. CME reports that their preliminary geological mapping and sampling indicates that Edum Banso's geology is consistent with previous interpretations and confirms earlier reports of quartz veins containing anomalous gold in outcrop. CME's limited rock sampling returned 4 anomalous gold results.
Discovery Gold Corp. (DCGD), closed Thursday at $0.053, down 18.46%, on 516,553 volume with 51 trades. The stock's 52-week low/high is $0.026/$0.59.
Hyperera, Inc. (HYRR)
Today we are reporting on Hyperera, Inc. (HYRR), here at the QualityStocks Daily Newsletter.
A high-technology company, Hyperera, Inc. specializes in the sale of hardware and software and the customization of clinical information system software for medical clinics and hospitals in China and throughout Asia. They offer their Hyperera ICU clinic information system for hospitals, doctors, nurses, and patients, and the Hyperera surgery anesthesia workstation.
In addition, they provide software development, maintenance, and up gradation services. Founded in 2008, Hyperera has their headquarters in Chicago, Illinois. The Company's shares trade on the OTCQB. Hyperera has been developing their infrastructure to begin to market the clinical information system software and hardware.
Beijing Chaoran Chuangshi Technology Co., Ltd. (Beijing Chaoran) developed the Clinical Information System in China. It was established in 2002, specializing in technology development and service, and sales of computer hardware and software, machine, and electric equipment. Beijing Chaoran is located in Beijing, China. Beijing Chaoran is a Chinese Technology company. They are owned 100 percent by Mr. Liancheng Li, the father of Hyperera's Chairman Zhi Yong Li.
On March 1, 2009, Hyperera signed a three-year software distribution agreement with Beijing Chaoran. With this agreement, Beijing Chaoran authorized Hyperera to be their exclusive sales and service agent for surgery anesthesia clinic management software and ICU management system product lines. The product lines include the products that Beijing Chaoran developed before the agreement signed and the products that will be developed by Beijing Chaoran during the term of the agreement. Beijing Chaoran is the exclusive supplier of the products Hyperera sells.
In addition, Hyperera is planning their future wastewater treatment business. The Company's intention in the near future is to begin a new line of business, which is a project to purify the wastewater from a variety of industries. These include biochemical, aquaculture and food processing and brewing. In the first stage, Hyperera will focus on pesticide wastewater processing.
The treatment process involves treating the wastewater in a number of steps. These include - mixed with air and catalyst in a pre-mixer, pressurized by a screw pump, and passed through an "ultrasonic, microwave catalytic reactor" and "electric flocculation reactor". These steps also include - mixed with air and catalyst again and passed through a "magnetic catalytic reactor" for completion of the gas-liquid homogenization, passed through a cyclone HCR deep well biofilter, and passed through the screening of inorganic ultrafiltration membrane filtration treatment for final discharge. The resultant sludge after dewatering by centrifuge may be sold as organic fertilizer.
Hyperera, Inc. (HYRR), closed Thursday's trading session at $0.50, up 116.26%, on 3,000 volume with 1 trade. The stock's 52-week low/high is $0.10/$1.00.
Northstar Global Business Services, Inc. (MDIN)
Wallstreetlivechat reported recently on Northstar Global Business Services, Inc. (MDIN), PennyTrader, OTC Picks, Stock Traders Chat, OTCReporter, StockEgg, Penny Invest did previously, and we're highlighting the Company today, here at the QualityStocks Daily Newsletter.
Founded in 1996, Northstar Global Business Services, Inc.'s commitment is to producing the best alternative healthcare products. The most popular products the Company has are Snorenz©, a patented spray for snoring relief and "Good Night's Sleep", an FDA approved sleep aid. The Company formerly went by the name Med Gen, Inc. They changed their name to Northstar Global Business Services, Inc. on August 4, 2010.
Northstar Global's corporate headquarters are in Holbrook, New York. The Company's subsidiary is NorthStar Business and Property Brokers, Inc. This subsidiary mainly engages in business brokering. They engage in buying and selling businesses and commercial properties in the U.S. Additionally, they provide mergers and acquisitions (M&A), third party financing, commercial real estate brokerage, franchising and business consulting, equipment leasing and accounts receivable factoring, as well as commercial insurance services.
Concerning the aforementioned alternative healthcare products, most of Northstar Global's products utilize an innovative spray delivery system. In addition, the products have received very positive consumer reviews globally, selling multiple millions of units from 1996 to the present.
Today, Northstar Global Business Services announced that they already commenced manufacturing product for an immense push into Europe with the Company's anti-snoring product, Snorenz. Once Snorenz is selling across Europe, they have plans to follow it soon with their other product lines. Manufacturing is already taking place. Snorenz is a throat spray that reduces or eliminates the sounds typically associated with snoring. This product is free of artificial colors, flavors or preservatives. Its patented ingredients, technology and manufacturing process delivers consistent and measured droplet spray mists directly to the back of the throat, lubricating the uvula and soft palate that vibrate with each breath.
The Company will be prepared to ship approximately one million units starting August 1, 2013 to supply the initial non-U.S. orders of the product. Outside the United States, the retail price of a 2-ounce bottle of Snorenz will be slightly higher, at approximately the equivalent of $14.00 USD. However, the net profit to Northstar Global Business Services will be roughly the same.
Northstar Global Business Services, Inc. (MDIN), closed Thursday's trading session at $0.005, down 15.25%, on 17,526,506 volume with 78 trades. The stock's 52-week low/high is $0.0001/$0.0107.
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.3175, up 2.42%, on 164,317 volume with 50 trades. The stock’s average daily volume over the past 60 days is 318,416, and its 52-week low/high is $0.161/$0.5995.
International Stem Cell Corp. announced that the company will host a conference call this Friday, March 22, at 11:00 a.m. ET, covering the exciting safety and efficacy results of their Parkinson's Disease study in cell-based therapeutic applications of ISCO's proprietary human parthenogenetic stem cell (hpSCs) technology. The results were offered just yesterday at influential industry conference, the American Academy of Neurology 65th Annual Meeting and ISCO's presenters, VP of R&D, Dr. Ruslan Semechkin, as well as the company's Exec. VP, Dr. Simon Craw, will be on hand tomorrow for the call.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company was first to perfect the natural phenomenon of parthenogenesis, which utilizes unfertilized human eggs to create hpSCs. These stem cells, created in a particular form called HLA homozygous, can be immune-matched to millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
hpSCs are as pluripotent as embryonic stem cells (ESCs) and have significant therapeutic potential but their creation does not involve the destruction of a viable human embryo – thus sidestepping the controversy and ethical dilemmas associated with the use of human embryonic stem cells. Different from induced pluripotent stem cells (iPSs), hpSCs do not involve manipulation of gene expression back to a less differentiated stage – a practice that may become a safety or regulatory obstacle in clinical applications.
A relatively small number of hpSC lines can offer the potential of producing the first true stem cell bank, UniStemCell, which ISCO intends to create as a means of serving populations across the globe. The company's scientists are currently focused on using hpSC to treat severe diseases of the eye, nervous system, and liver, for which cell therapy has been clinically proven but is limited due to the unavailability of safe human cells.
In addition to its therapeutic focus, ISCO also provides two revenue streams. Firstly through its subsidiary Lifeline Cell Technology, specialized cells and growth media for biological research around the world, and secondly its subsidiary Lifeline Skin Care, the company manufactures and sells anti-aging skincare products utilizing an extract from the hpSC and by leveraging the latest discoveries in the fields of stem cell biology, nanotechnology, and skin cream formulation technology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell to Host Conference Call on Friday, March 22 to Discuss Positive Study Data of Parkinson's Disease
International Stem Cell Corporation Announces Positive Results of Primate Parkinson's Study
International Stem Cell Corporation Technology for Deriving Neuronal Cell Published by Nature Publishing Group
VentriPoint Diagnostics Ltd. (VPTDF)
The QualityStocks Daily Newsletter would like to spotlight VentriPoint Diagnostics Ltd. (VPTDF). Today, VentriPoint Diagnostics Ltd. closed trading at $0.09, off by 8.16%, on 44,000 volume with 3 trades. The stock’s average daily volume over the past 60 days is 58,046, and its 52-week low/high is $0.073/$0.187.
VentriPoint Diagnostics Ltd. reported today that the company has filed for CE Mark and Health Canada approvals for their NRV database (non-specific heart disease), which allows clinicians to rapidly assesses RV (right ventricle) status with exceptional accuracy across an entire swathe of patients at once. This tool allows for selective assessment and can pick out the patients who lack significant congenital heart defects or Pulmonary Arterial Hypertension (PAH), yet may have a variety of other conditions, such as left-heart failure or valve disease. This move will satisfy the overwhelming demand from customers looking for a comprehensive NRV application so they can assess the RV in virtually every patient they see.
VentriPoint Diagnostics Ltd. (VPTDF) leverages knowledge-based techniques to make heart analysis more convenient and less expensive. Having already installed multiple VMS™ analysis systems for heart testing in leading cardiac centers in Europe, Canada and the United States, the company is currently focused on expanding the applications of its technology beyond congenital heart disease in adults and children.
VMS™ is the first cost-effective and accurate diagnostic tool for measuring right ventricle heart function. The company designed its analysis system to be used for all major heart diseases, including pulmonary hypertension, cardiovascular disease, and heart failure. Canada and Europe (CE Mark) have granted approval for the sale of the VMS™ diagnostic tool, and VentriPoint is pursuing the US-FDA approval through the 510(k) process.
The company’s VMS™ analysis systems eliminate all the disadvantages of an MRI scan, including a long wait list, the one-hour scan time, the claustrophobic environment, the requirement of a general anesthetic for children, the lengthy heart analysis process, and the need for a second trip to the hospital. Offering better efficiency and cost savings, VMS™ offers the healthcare industry a superior method of heart visualization.
The management team executing VentriPoint’s business strategy retains extensive experience in both healthcare technology and business development. Many expansion opportunities exist for the company’s technology with a total market potential exceeding $1 billion. As a leader in the clinical diagnostics market, the company is well positioned to meet the well-defined clinical need for efficient, accurate, and inexpensive heart analysis. Disclaimer
VentriPoint Diagnostics Ltd. Company Blog
VentriPoint Diagnostics Ltd. News:
VentriPoint Applies for European and Canadian Approvals for A New Application for Non-Specific Heart Disease
VentriPoint Announces $2 Million Unit Private Placement
VentriPoint Receives US-FDA Acceptance of 510 (K) Submission for Pulmonary Arterial Hypertension
VIASPACE, Inc. (VSPC)
The QualityStocks Daily Newsletter would like to spotlight VIASPACE, Inc. (VSPC). Today, VIASPACE, Inc. closed trading at $0.0158, up 5.33%, on 392,511 volume with 12 trades. The stock’s average daily volume over the past 60 days is 2,320,110, and its 52-week low/high is $0.0013/$0.0158.
VIASPACE, Inc. (VSPC) is focused on growing renewable Giant King™ Grass as a low-carbon fuel for clean electricity generation and environmentally friendly energy pellets, as well as a feedstock for bio-methane production, green cellulosic biofuels, biochemical, and biomaterials. A high-yield, low-cost feedstock, Giant King Grass meets the cost targets of green energy applications while maintaining a carbon neutral profile.
The highest yielding biomass crop in the world, Giant King Grass can grow in a variety of soil conditions and does not compete with food crops. Once Giant King Grass is established, it can be harvested at 3-5 feet tall every 45 to 60 days or at 14 feet tall twice a year. This incredibly high rate of growth provides a continual supply of biomass year-round, enabling strategically located power plants to operate 24 hours a day regardless of the current season.
VIASPACE provides Giant King™ Grass seedlings and technical expertise to qualified projects. The company also plans to serve as a project developer or co-developer for power plant or pellet mill projects, together with local partners that have land and require electricity, heat, pellets, biogas, or biofuels. VIASPACE and its partners are capable of delivering an integrated Giant King Grass plantation and biomass power plant project in just 24 months.
The excellent energy characteristics of Giant King Grass and its ability to be harvested multiple times each year enable and energy output yield that is much higher than other crops . This superior feedstock offers material productivity benefits at remarkable costs for energy production, biofuels, and biomaterials. Giant King Grass is currently being grown in the United States, Virgin Islands, China, and other areas. Disclaimer
VIASPACE, Inc. Company Blog
VIASPACE, Inc. News:
VIASPACE Chairman Interviews with CEONEWS.Tv Regarding Business Dynamics and Recent Corporate Milestones
VIASPACE Announces Contract With AGRICORP And Giant King Grass Growing In Nicaragua
25 Acres of Giant King Grass Shipped by VIASPACE and Growing in St. Croix
Soul and Vibe Interactive, Inc. (SOUL)
The QualityStocks Daily Newsletter would like to spotlight Soul and Vibe Interactive, Inc. (SOUL). Today, Soul and Vibe Interactive, Inc. closed trading at $0.325, up 0.62%, on 5,894 volume with 7 trades. The stock’s average daily volume over the past 60 days is 208,435, and its 52-week low/high is $0.26/$1.45.
Soul and Vibe Interactive, Inc. (SOUL) is a publisher of games and game-related content for consoles, mobile devices, and personal computers. The company specializes in creating original intellectual properties and has extensive experience licensing world-renowned brands from influential companies. Notably, Soul and Vibe is the only company with the right to license General Mills brands for video game applications.
Leveraging partnerships with software developers around the world, Soul and Vibe transforms unique concepts into engaging and affordable entertainment experiences. The game publisher has established game development and publishing agreements for the Xbox 360® video game and entertainment system, Windows 8, Windows Live, and Windows Phone from Microsoft, and the PlayStation® 3 computer entertainment system and PlayStation® Vita (PS Vita) from Sony.
Soul and Vibe stands out from the crowd by breaking through marketplace clutter and noise via direct-to-consumer tactics that reverberate from the core player to the mainstream gaming audience. Making games as fun to talk about as they are to play is a key focus of the company. The more personable and memorable the play experience, the more likely consumers and press will talk about the game and its publisher.
The burgeoning game industry spans across diverse demographics and offers wide-ranging opportunities for profit and growth. Consumer spending on console, mobile, and personal computer game software exceeded $56 billion in 2010 and is projected to reach $82 billion by 2015. This revenue represents more than 2x the size of the music industry and nearly 3/5th the size of the entire film industry. Disclaimer
Soul and Vibe Interactive, Inc. Company Blog
Soul and Vibe Interactive, Inc. News:
Soul and Vibe to Pursue Business Development Deals at Game Connection Conference in San Francisco
Soul and Vibe to Monetize Avatars to Create Marketing Impressions and Additional Revenues
Soul and Vibe's Mobile Games to Serve as Revenue-Generating Marketing Vehicles for Its High-Value Console and PC Games
International Stem Cell Corp., a California-based biotechnology company focused on therapeutic applications of human parthenogenetic stem cells (hpSCs), just announced that it will be hosting a conference call tomorrow morning to discuss results of its Parkinson’s Disease study that it presented at the American Academy of Neurology 65th Annual Meeting (AAN) this week. Dr. Ruslan Semechkin, Vice President of Research and Development for ISCO and Dr. Simon Craw, Executive Vice President, will host the call.
Date: March 22, 2013
Time: 11:00 a.m. ET
Conference Line (U.S.): 1-888-846-5003
International Dial-In: 1-480-629-9856
Conference ID: 4610097
The stem cell company advises interested parties to join at least 10 minutes before the start time. A supplementary slide deck is available at the newsroom section of ISCO’s website at:www.internationalstemcell.com/Company_Presentation.
A playback of the call will be available shortly after the call’s conclusion. To listen, call 1-877-870-5176 within the United States or 1-858-384-5517 when calling internationally. When promoted, use the following replay pin number: 4610097.
For more information, visit www.internationalstemcell.com
Today before the opening bell, VentriPoint Diagnostics announced it has filed for CE Mark and Health Canada approvals for its database for non-specific heart disease (NRV). By using this database, clinicians can rapidly and accurately assess the status of the right ventricle (RV) in all patients that do not have significant congenital heart defects or Pulmonary Arterial Hypertension (PAH), yet may have a variety of other conditions, such as left-heart failure or valve disease.
“Our customers have asked for the NRV application so they can assess the RV in virtually every patient they see,” said Dr. George Adams, CEO of VentriPoint. “RV assessments are important in all heart patients and we are proud to offer this cost-effective extension to our VMS™ products.”
Approximately 27 million people in the world population have some form of heart disease. VentriPoint Diagnostics’ NRV database will provide a direct avenue for clinicians to better evaluate and care for these individuals. VentriPoint Diagnostics anticipates receiving a response from the European CE Mark and Health Canada offices in the next 30 days.
The database will be used alongside the VMS-2DE™ heart analysis system for patients where knowledge of the function of the right heart could be used to assess the overall heart function to optimally treat the patient. It can also be used to provide a reference baseline study for patients who are at risk for developing right heart dysfunction and would benefit from regular monitoring. Medical research has shown an accurate understanding of the right heart function greatly informs the physician of both right and left heart failure, but it has been hard to obtain this information in a rapid and cost-effective manner until now.
The VMS-2DE™ is approved for clinical use in Tetralogy of Fallot, dextro-Transposition of the Great Arteries (d-TGA) and PAH in Canada and Europe and is for investigational use only in the United States.
For more information, visit www.ventripoint.com
The Guitammer Company, an Ohio based company that develops and markets “4D” systems that translate low frequency sounds into tactile vibrations to enhance public or in-home entertainment experiences, recently listed an unregistered sale of equity securities, for a total consideration of $250,000. In a private transaction, the company sold 1,000,000 units for $0.25 per unit, with each unit consisting of one share of the company’s common stock plus a two year warrant to purchase one share of common stock for $.36 per share.
The company claims an exemption from registration afforded by Section 4(2) of the Securities Act of 1933, as amended, since the sale did not involve a public offering, and the buyer took the shares for investment and not resale. The company took appropriate measures to restrict transfer of such shares and warrants.
The sale follows the growing company’s recent reporting of a 64% jump in annual revenues, together with a higher gross profit and stronger balance sheet. Revenues for the year ended December 31, 2012, were $2.13 million, with a gross margin of 40%. Nearly $1.5 million in debt has also been removed. In addition, roughly $1.7 million was raised in private placements during the year.
The company’s low frequency audio transducers are used around the world by leading entertainment and theater companies such as AMC, IMAX, and Disney, in movie theaters and attractions, as well as by world-famous musicians, in home theaters, for car audio, and for simulators, and the private placement funds will help support Guitammer’s aggressive growth strategy. The President of the company, Mark Luden, is on record as stating that he believes they are positioned for a “breakout year in 2013.”
For more information, visit www.guitammer.com
FieldPoint Petroleum, an oil and gas company with a sprawling footprint across Louisiana, New Mexico, Oklahoma, Texas, and Wyoming, was happy to report record FY12 (ended Dec 31) financials today, including a 44% jump in revenues on over $2.11M net income (compared to just over $600k in 2011).
Yes, you read that right, net income is up 250% from the prior year. It seems FPP really has a handle on the baseline logistics of their considerable portfolio of oil and gas properties, with key interests in rapidly emerging plays, like the slated 10% interest to be earned in the exciting Riverdale Prospect in Texas (drilling set to kick off in the second half of this year).
President and CEO of FPP, Ray Reaves, commented on the exemplary bottom-line performance of the company, which has now been empirically highlighted via the record-breaking financials, pointing to the two most significant events of the year as high-water marks of progress, the completion of their first two wells in the Lusk Field (87.5%-100% WI, Lea County, NM). Both of these wells carried a good portion of the load in helping to accomplish this financial feat and plans are already in motion to sink a third well on the Lusk site that should add considerable weight to long-term reserve and production figures.
Reaves is basically tipping his hat to markets here about the impact Lusk alone will have on 2013 financials, which are already shaping up quite nicely. Reaves underscored the 225% climb in basic EPS to $0.26 (212.5% jump in fully diluted), confident that this robust indicator of the company’s performance will be a hallmark for investors and that the real story goes even further than 2012 being the best year in the company’s history in many respects, speaking to the future of the company.
Looks like the company will also be taking a crack at drilling a development well in Goliad County, Texas, at the aforementioned Riverdale Prospect as well (targeting the Wilcox formation at around 8.9k feet). This development work in Goliad County, in conjunction with the new Lusk well, should indeed add mightily to the company’s reserves and production, with the leading indicators for 2013 financial performance increasing accordingly.
Energy costs are rising and Reaves is supremely confident about the future of the macro picture. When you see a hot little hydrocarbon producer like this doubling-down on the back of a banner year, it’s not hard to read the signals. FPP has some 304 gross productive wells (82.53 net) under their belt at last count, with operator status on 59 of them and the intention of obtaining primary operator status on the majority of the overall footprint where economic interests mandate it.
To learn more about FieldPoint Petroleum, check out www.FPPcorp.com
Today's Top 3
Penny Stock Heroes
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) Nominated for Best Early-Stage Vaccine Biotech at 6th Annual Vaccine Industry Excellence Awards
- Consorteum Holdings, Inc. (CSRH) Reaches Funding Agreement With Private Equity Group
- Cardium Therapeutics, Inc. (CXM) Receives ISO Certification for Excellagen
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- HII Technologies, Inc. (HIIT) Announces Engagement of QualityStocks Investor Relations Services
- International Stem Cell Corp. (ISCO) to Host Conference Call on Friday, March 22 to Discuss Positive Study Data of Parkinson's Disease
- Loans4Less.com, Inc. (LFLS) Engages CPA Firm to Audit Financials
- Rainbow Coral Corp. (RBCC) Forms Joint Venture With Cutting-Edge Drug Delivery Company TheraKine
- Soul and Vibe Interactive Inc. (SOUL) to Pursue Business Development Deals at Game Connection Conference in San Francisco
- The Guitammer Company Inc. (GTMM) Lumiere Pavilions Jump Start Chinese New Year With Eighth Theater Installation of GTMM's Patented "4D" Technology
- VentriPoint Diagnostics Ltd. (VPTDF) Applies for European and Canadian Approvals for A New Application for Non-Specific Heart Disease
- Viaspace, Inc. (VSPC) 25 Acres of Giant King Grass Shipped and Growing in St. Croix
- Viscount Systems, Inc. (VSYS) Freedom Access Control Technology Secures Dallas High Rises
- VistaGen Therapeutics, Inc. (VSTA) to Present Enhancements and Expanded Validation of LiverSafe 3Dô at Society of Toxicology's 52nd Annual Meeting